Kamakura, Japan

Shu Matsumoto

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 4.6

ph-index = 4

Forward Citations = 79(Granted Patents)


Company Filing History:


Years Active: 1992-1996

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Shu Matsumoto

Introduction

Shu Matsumoto is a prominent inventor based in Kamakura, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds with therapeutic applications. With a total of 5 patents to his name, Matsumoto's work has garnered attention in the scientific community.

Latest Patents

Matsumoto's latest patents include innovative compounds such as indole derivatives. This invention is directed to an indole derivative represented by a specific general formula, which includes various alkyl and aryl groups. The compound serves as an immunorepressing agent, showcasing its potential in therapeutic applications. Another notable patent is a composition for suppressing the infiltration of eosinophils. This agent comprises a tricyclic triazolo derivative that effectively suppresses eosinophil infiltration into inflammatory regions, highlighting its importance in treating inflammatory conditions.

Career Highlights

Shu Matsumoto is currently associated with Toray Industries, Inc., a leading company in the field of advanced materials and chemicals. His work at Toray has allowed him to focus on innovative research and development, contributing to the company's reputation for excellence in the industry.

Collaborations

Matsumoto has collaborated with notable colleagues such as Hiroshi Nagase and Koji Kawai. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of research.

Conclusion

Shu Matsumoto's contributions to the field of pharmaceuticals through his innovative patents and collaborations underscore his role as a significant inventor. His work continues to impact the scientific community and holds promise for future advancements in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…